Inovio Biomedical Corporation to Present at DNA Vaccines 2010 Conference

SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that representatives and associates of the company will make multiple presentations at the DNA Vaccines 2010 conference being held in New Orleans, LA, March 2-4th.

MORE ON THIS TOPIC